These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 20837752)

  • 21. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.
    Sakoulas G; Alder J; Thauvin-Eliopoulos C; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1581-5. PubMed ID: 16569891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.
    Shoji M; Cui L; Iizuka R; Komoto A; Neoh HM; Watanabe Y; Hishinuma T; Hiramatsu K
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3870-81. PubMed ID: 21628539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing.
    Chen CJ; Lin MH; Shu JC; Lu JJ
    J Antimicrob Chemother; 2014 Feb; 69(2):349-54. PubMed ID: 24092658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
    Pillai SK; Gold HS; Sakoulas G; Wennersten C; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2223-5. PubMed ID: 17404001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of resistance to daptomycin in Staphylococcus aureus.
    Gómez Casanova N; Siller Ruiz M; Muñoz Bellido JL
    Rev Esp Quimioter; 2017 Dec; 30(6):391-396. PubMed ID: 29082727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation of RNA polymerase β-subunit gene promotes heterogeneous-to-homogeneous conversion of β-lactam resistance in methicillin-resistant Staphylococcus aureus.
    Aiba Y; Katayama Y; Hishinuma T; Murakami-Kuroda H; Cui L; Hiramatsu K
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4861-71. PubMed ID: 23877693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.
    Julian K; Kosowska-Shick K; Whitener C; Roos M; Labischinski H; Rubio A; Parent L; Ednie L; Koeth L; Bogdanovich T; Appelbaum PC
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3445-8. PubMed ID: 17620372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daptomycin Resistance and Tolerance Due to Loss of Function in Staphylococcus aureus
    Barros EM; Martin MJ; Selleck EM; Lebreton F; Sampaio JLM; Gilmore MS
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome sequence of Staphylococcus aureus VC40, a vancomycin- and daptomycin-resistant strain, to study the genetics of development of resistance to currently applied last-resort antibiotics.
    Sass P; Berscheid A; Jansen A; Oedenkoven M; Szekat C; Strittmatter A; Gottschalk G; Bierbaum G
    J Bacteriol; 2012 Apr; 194(8):2107-8. PubMed ID: 22461548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of Daptomycin Resistance in Coagulase-Negative Staphylococci Involves Mutations of the Essential Two-Component Regulator WalKR.
    Jiang JH; Dexter C; Cameron DR; Monk IR; Baines SL; Abbott IJ; Spelman DW; Kostoulias X; Nethercott C; Howden BP; Peleg AY
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
    Kanesaka I; Fujisaki S; Aiba Y; Watanabe S; Mikawa T; Katsuse AK; Takahashi H; Cui L; Kobayashi I
    J Infect Chemother; 2019 Jan; 25(1):1-5. PubMed ID: 30322736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS.
    Berscheid A; François P; Strittmatter A; Gottschalk G; Schrenzel J; Sass P; Bierbaum G
    J Antimicrob Chemother; 2014 Dec; 69(12):3190-8. PubMed ID: 25103491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-nucleotide polymorphisms in a vancomycin-resistant Staphylococcus aureus strain based on whole-genome sequencing.
    Kim JW; Lee KJ
    Arch Microbiol; 2020 Oct; 202(8):2255-2261. PubMed ID: 32535788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
    J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.
    Sader HS; Fritsche TR; Jones RN
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2330-6. PubMed ID: 16801409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus.
    Watanabe Y; Cui L; Katayama Y; Kozue K; Hiramatsu K
    J Clin Microbiol; 2011 Jul; 49(7):2680-4. PubMed ID: 21525224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association.
    Alam MT; Petit RA; Crispell EK; Thornton TA; Conneely KN; Jiang Y; Satola SW; Read TD
    Genome Biol Evol; 2014 Apr; 6(5):1174-85. PubMed ID: 24787619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure.
    Kelley PG; Gao W; Ward PB; Howden BP
    J Antimicrob Chemother; 2011 May; 66(5):1057-60. PubMed ID: 21393156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective
    Freeman CD; Hansen T; Urbauer R; Wilkinson BJ; Singh VK; Hines KM
    mSphere; 2024 Jun; 9(6):e0011524. PubMed ID: 38752757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.